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Monday, February 9, 2015 277ato elicit an effect, as if the ‘‘apo’’ configuration required the loss of both side
chains. Thus, the intrinsic ligand of the CNB homology domain (CNBhD) re-
duces the stability of the closed state relative to the open state. To determine
whether the AA mutant phenotype represents a loss of function, we deleted
the CNBhD. In contrast to the AA mutant, the deletion gave rise to faster
activation kinetics but a more dramatic g-V shift of þ40 mV. This finding
indicates that, unlike HCN channel, in which the unliganded CNBD mimics
the CNBD deletion, the AA mutant phenotype is not a loss of function of
the CNBhD. Instead, both the intrinsically-liganded and apo conformations
communicate with the gating machinery. The current properties can be
recapitulated by a 7-state allosteric model, in which the AA mutant alters
multiple transitions during channel gating whereas CNBhD deletion affects
only the last opening step. We conclude that the EAG1 CNBhD serves a func-
tion mechanistically distinct from those of the corresponding domains in
channels gated by cyclic nucleotides despite extensive sequence and structural
homology.
1391-Pos Board B342
An Eag Domain Polypeptide Regulates the Deactivation Kinetics of the
hERG 1A-3.1 Splice Variant Linked to Schizophrenia
Curtis D. Gallagher, Matthew C. Trudeau.
Physiology, University of Maryland, Baltimore, Baltimore, MD, USA.
The Human Ether-a´-go-go Related Gene (hERG) encodes a voltage-activated
Kþ channel. hERG contributes to the repolarization of the ventricular action
potential as the primary component of the cardiac delayed rectifier Kþ current
(IKr) and has also been shown by many groups to modulate neuronal firing fre-
quency. Disruption of channel function by inherited mutations in the gene
encoding hERG has been shown to cause type 2 long QT syndrome (LQT2).
hERG gating is characterized by rapid inactivation upon depolarization and
rapid recovery from inactivation and slow closing (deactivation) upon repolar-
ization. Unlike other Kþ channels, hERG, ELK and EAG channels contain an
N-terminal eag domain, composed of a PAS domain and a PAS-Cap domain in
the N-terminal region. Inter-subunit interactions between the N-terminal eag
domain and the C-terminal cyclic-nucleotide binding homology domain regu-
late slow deactivation kinetics in the original variant of hERG, hERG1a chan-
nels. A recently discovered splice variant, hERG 1a-3.1, has much faster
deactivation and has been linked to schizophrenia. We demonstrate in
HEK293 cells, that co-expression of hERG1a-3.1 with soluble eag domain pep-
tide partially rescues deactivation kinetics, presumably by providing a fully
functional eag domain to the eag-truncated hERG1a-3.1 to slow channel deac-
tivation. Cells co-expressing hERG1a-3.1 þ eag domain polypeptides had
significantly slower fast and slow time constants of deactivation compared to
hERG1a-3.1 channels alone (p<0.05). We conclude that eag domain polypep-
tides are able to partially restore deactivation gating. Current experiments are
utilizing FRET to assess if the hERG1a-3.1 C-terminus interaction with the
eag domain is physically disrupted.
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In drosophila, the tetrameric Ether-a`-go-go (EAG) voltage-gated Kþ channel
contains in its C-terminal cytoplasmic region a substrate-like binding
domain for Ca2þ/calmodulin-dependent protein kinase II (CaMKII-BD).
This Ser/Thr kinase forms a dodecamer and each subunit includes an
association domain mediating multimerization and a catalytic domain corre-
sponding to the typical protein kinase fold. In between these domains,
CaMKII contains a regulatory segment (RS) harboring a CaMKII-BD with
homology to that of EAG followed by a Ca2þ/CaM-binding region. This
RS has a regulatory role, mediating the inhibition and activation of the kinase.
CaMKII is activated by Ca2þ/CaM-binding and can become Ca2þ/CaM-inde-
pendent upon phosphorylation of its CaMKII-BD. EAG is phosphorylated by
CaMKII in vivo, and the two proteins form a stable complex in vitro.
CaMKII-bound EAG keeps the kinase active in the absence of Ca2þ/CaM
and autophosphorylation.
The interaction of the constitutively active CaMKII kinase domain with the
EAG CaMKII-BD has been characterized. The measurement of KD values
showed that the EAG CaMKII-BD is a high affinity CaMKII substrate, lying
in the nanomolar range in comparison with the micromolar range of typical
protein kinase substrates. Crystal structures were determined for the ternary
complexes CaMKII-Mg2þ/ATP-EAG and CaMKII-Mg2þ/ADP-EAGP corre-
sponding to the initial and final states of the trans-phosphorylation mecha-nism, respectively. These structures are globally very similar, with relative
rearrangements at the catalytic site. An alanine scan of the EAG residues
lying at the CaMKII-EAG interface revealed that practically every residue
contributes significantly for the binding strength of the complex. The associ-
ation of the two proteins in the cell might lie beyond the usual transient
kinase-substrate association model, likely corresponding to a long-lasting
robust complex.
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KvLQT1 and hERG are the voltage-gated Kþ channel a-subunits of the car-
diac repolarizing currents IKs and IKr, respectively. These currents function
in vivo with some redundancy to maintain appropriate action potential
durations (APDs) in cardiomyocytes. As such, protein-protein interactions
between hERG and KvLQT1 may be important in normal cardiac electrophys-
iology, as well as in arrhythmia and sudden cardiac death. Previous phenom-
enological observations of functional, mutual downregulation between these
complementary repolarizing currents in transgenic rabbit models have moti-
vated our investigations into interactions between hERG and KvLQT1. More-
over, reports of interplay between hERG and KvLQT1 have been described
both in the literature and anecdotally, and our recent work demonstrated
that the interaction is mediated by the C-termini of both a-subunits and is
modulated by cAMP. We hypothesize that direct binding of cAMP to the pu-
tative cyclic nucleotide binding domain (CNBD) in the hERG C-terminus ab-
rogates hERG-KvLQT1 interactions, as assessed by FRET analyses. We have
developed ion channel fusions to GFP variants, which include hERG CNBD
mutants as well as phospho-null and phospho-mimetic mutants. cAMP levels
are altered in heterologous cells expressing ion channel constructs through
membrane-permeable cAMP analogs or forskolin along with IBMX. Through
classic biochemical assays and quantitative FRET approaches, we aim to
delineate the direct role of cAMP from that of downstream, PKA-mediated
effects in regulating interactions between KvLQT1 and hERG in model sys-
tems. This work potentially furthers our understanding of hERG-KvLQT1
interactions and may elucidate mechanisms that underlie many types of
arrhythmia as well as characterize novel interactions between two distinct po-
tassium channel families.
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The mitochondrial large-conductance Ca2þ -activated Kþ channel (mitoBKCa)
of adult cardiomyocytes contains a C-terminal 50 amino acid insert (DEC)
as essential for mitochondrial targeting. The activation of mitochondrial BK
channels (mitoBKCa) protects the heart from ischemia and reperfusion injury,
highlighting its significant role in cardiac function. Here, we characterized the
subproteome of mitoBKCa in cardiomyocytes in the quest to better understand
its physiological and pathological relevance in the heart. To this end, we used
GST-DEC and GST proteins to pull down proteins interacting with DEC using
cardiomyocyte lysates and mitochondrial lysates. We also used monoclonal
BK antibody and IgG to immunoprecipitate proteins interacting with
mitoBKCa using Percoll purified mitochondrial lysates from whole heart. In
all, we identified 212 cellular proteins and 157 mitochondrial proteins inter-
acting with DEC; and 60 mitochondrial proteins interacting with mitoBKCa.
Gene oncology analysis revealed mitoBKCa potential contribution to multiple
cellular functions. It could contribute to oxidative respiration through cyto-
chrome c oxidase (5 subunits) and ADP/ATP translocase (AAC), including
AAC1 (10 peptides, n¼2) and AAC2 (13 peptides, n¼2), and regulate mito-
chondrial metabolism through acetyl-Coenzyme transferase 2 (7 peptides,
n¼2). In addition, our data revealed that mitoBKCa has a broader impact.
It might facilitate the pathological process of Parkinson’s disease and multiple
types of cancer by interacting with critical enzymes, such as NADH dehydro-
genase (7 subunits, 3-7 peptides each) and integrin linked kinase (2 peptides,
n ¼1). Excitingly, mitoBKCa interacted with 15 different subunits of the ATP
synthase, which forms the permeability transition pore, underscoring a new
mechanism for mitoBKCa to protect the heart. In summary, proteomic anal-
ysis identified a wide variety of cellular and mitochondrial proteins forming
complex with mitoBKCa channel, revealing new paradigms for BK channel
function.
